Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07720037Phase 4Not yet recruiting
A Phase 4 trial of vonoprazan in Helicobacter pylori infection, sponsored by Shandong University. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07720037.